文献速递其他结缔组织病

利用基因操作cDNA开发可高效检测抗核含缬酪肽蛋白样蛋白2(NVL2)自身抗体的酶联免疫吸附试验

Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA.
PubMed 文献 · RMD Open · 2025-08-07

研究纳入1676例多种疾病患者血清,用基因操作cDNA克隆表达的重组NVL2蛋白建立酶联免疫吸附试验(ELISA),检测抗NVL2抗体。18份抗核仁抗体(ANoA)阳性血清经ELISA判为阳性并经免疫沉淀-免疫印迹确认,其中6例为系统性硬化症(SSc);抗NVL2抗体阳性SSc患者的ELISA滴度显著高于抗NVL2抗体阳性非SSc患者(p<0.042)。

要点

  • 在ANoA阳性血清中,18份经抗修饰NVL2(mNVL2)ELISA判为阳性并经免疫沉淀-免疫印迹确认。
  • 抗NVL2抗体在间接免疫荧光均质核仁型(AC-8)中检出率为17.0%。
  • 抗NVL2抗体阳性者包括6例SSc、5例特发性间质性肺炎和7例其他疾病患者。

核心结论

  • 据作者所知,本研究发现的抗NVL2抗体阳性病例数多于既往任何研究。
  • 该ELISA显示抗NVL2抗体滴度与SSc诊断相关,有望拓展对於抗NVL2抗体的认识。

研究设计与样本

  • 研究纳入1676例多种疾病患者血清,包括167份ANoA阳性血清、120份ANoA阴性血清和17份健康对照血清。
  • 采用基因操作cDNA克隆表达的重组NVL2蛋白(修饰NVL2,mNVL2)建立ELISA检测抗NVL2抗体。
  • 对18份ANoA阳性血清行间接免疫荧光(IIF),并用抗mNVL2 ELISA检测,阳性结果经免疫沉淀-免疫印迹确认。

主要发现

  • 18份ANoA阳性血清经抗mNVL2 ELISA判为阳性,并经免疫沉淀-免疫印迹确认抗NVL2抗体阳性。
  • 1份ANoA阴性血清在抗mNVL2 ELISA中判为假阳性。
  • 抗NVL2抗体在IIF均质核仁型(AC-8)中的检出率为17.0%。
  • 抗NVL2抗体阳性者包括6例SSc患者、5例特发性间质性肺炎患者和7例其他疾病患者。
  • 抗NVL2抗体阳性SSc患者的抗mNVL2 ELISA滴度显著高于抗NVL2抗体阳性非SSc患者(p<0.042)。

关键数值与推荐

  • 抗NVL2抗体在IIF均质核仁型(AC-8)中的阳性率为17.0%。
  • 抗NVL2抗体阳性SSc患者与抗NVL2抗体阳性非SSc患者的抗mNVL2 ELISA滴度比较,p<0.042。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Antinuclear valosin-containing protein-like protein (NVL) antibodies have been detected only in systemic sclerosis (SSc) patients, and diverse comorbidities have been reported in anti-NVL antibody-positive SSc patients. Any relationship between antibodies against NVL1, a minor isoform of NVL, and the clinical symptoms also remains unclear. To clarify the clinical features of anti-NVL2 antibody-positive patients, we developed an ELISA for measuring antibodies against NVL2, a major target of autoantibodies against NVL. METHODS: Sera from 1676 patients with various conditions were included. 167 anti-nucleolar antibody (ANoA)-positive sera, 120 ANoA-negative sera and 17 healthy control sera were examined by an ELISA that uses the recombinant protein of NVL2 derived from its gene-manipulated complementary DNA clone (modified NVL2 (mNVL2)). RESULTS: 18 ANoA-positive sera subjected to indirect immunofluorescence (IIF) were positive for anti-mNVL2 ELISA. Although one ANoA-negative serum was judged false positive in our anti-mNVL2 ELISA, the above 18 anti-mNVL2 ELISA-positive sera were confirmed to be positive for anti-NVL2 antibodies by immunoprecipitation-Western blotting. Anti-NVL2 antibodies were detected in 17.0% of homogeneous nucleolar (AC-8) patterns in IIF. Six SSc patients had anti-NVL2 antibodies, whereas five with idiopathic interstitial pneumonia and seven with other diseases had anti-NVL2 antibodies. Anti-mNVL2 ELISA titres were significantly higher in the anti-NVL2 antibody-positive SSc patients than in the anti-NVL2 antibody-positive non-SSc patients (p<0.042). CONCLUSIONS: We found more anti-NVL2 antibody-positive cases than any previous study, as far as we know. Our ELISA, which showed an association between titres of these antibodies and SSc diagnosis, promises to expand knowledge about anti-NVL2 antibodies.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Yamashita Y, Yamano Y, Muro Y, et al. Development of an enzyme-linked immunosorbent assay for the efficient detection of autoantibodies against nuclear valosin-containing protein-like protein (NVL) 2 using its manipulated cDNA. RMD Open. 2025. PMID: 40780730. doi:10.1136/rmdopen-2025-005679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。